Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 511
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Fiprotec 67 mg V/DCP/14/0022 Beaphar B.V., Nīderlande QP53AX15 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0022-01 67 mg 1 Pipete, 1 deva -
V/DCP/14/0022-02 67 mg 2 Pipete, 1 deva -
V/DCP/14/0022-03 67 mg 3 Pipete, 1 deva -
V/DCP/14/0022-04 67 mg 6 Pipete, 1 deva -
V/DCP/14/0022-07 67 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-08 67 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-09 67 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-10 67 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0022-11 67 mg 6 Pipete alumīnija blisterī, 1 deva -
Fiprotec 134 mg V/DCP/14/0023 Beaphar B.V., Nīderlande QP53AX15 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0023-01 134 mg 1 Pipete, 1 deva -
V/DCP/14/0023-02 134 mg 2 Pipete, 1 deva -
V/DCP/14/0023-03 134 mg 3 Pipete, 1 deva -
V/DCP/14/0023-04 134 mg 6 Pipete, 1 deva -
V/DCP/14/0023-07 134 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-08 134 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-09 134 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-10 134 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0023-11 134 mg 6 Pipete alumīnija blisterī, 1 deva -
Fiprotec 268 mg V/DCP/14/0024 Beaphar B.V., Nīderlande QP53AX15 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0024-01 268 mg 1 Pipete, 1 deva -
V/DCP/14/0024-02 268 mg 2 Pipete, 1 deva -
V/DCP/14/0024-03 268 mg 3 Pipete, 1 deva -
V/DCP/14/0024-04 268 mg 6 Pipete, 1 deva -
V/DCP/14/0024-07 268 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-08 268 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-09 268 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-10 268 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0024-11 268 mg 6 Pipete alumīnija blisterī, 1 deva -
Ungezieferband Katze 2.1 g V/NRP/01/1337 Beaphar B.V., Nīderlande QP53AF03 cats Vairāk

Medicinal product information

Pharmaceutical form: collar
International name (active substance): Dimpylate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Beaphar B.V., Nīderlande
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 07052018LI (07-May-2018)
Labelling text: [PDF] 07052018M (07-May-2018)
Summary of product characteristics: [PDF] 07052018ZA (07-May-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1337-01 2,1 g 1 Papīra maisiņš, 1 deva -
Fiprotec 402 mg V/DCP/14/0025 Beaphar B.V., Nīderlande QP53AX15 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Fipronil
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Laboratorios Calier, S.A., Spānija;Beaphar BV, Nīderlande
Date of authorisation/renewal: 08-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/14/0025-01 402 mg 1 Pipete, 1 deva -
V/DCP/14/0025-02 402 mg 2 Pipete, 1 deva -
V/DCP/14/0025-03 402 mg 3 Pipete, 1 deva -
V/DCP/14/0025-04 402 mg 6 Pipete, 1 deva -
V/DCP/14/0025-07 402 mg 4 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-08 402 mg 1 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-09 402 mg 2 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-10 402 mg 3 Pipete alumīnija blisterī, 1 deva -
V/DCP/14/0025-11 402 mg 6 Pipete alumīnija blisterī, 1 deva -
Ungezieferband Hund 3.9 g V/NRP/11/0043 Beaphar B.V., Nīderlande QP53AF03 dogs Vairāk

Medicinal product information

Pharmaceutical form: collar
International name (active substance): Dimpylate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Beaphar B.V., Nīderlande
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 07052018LI (07-May-2018)
Labelling text: [PDF] 07052018M (07-May-2018)
Summary of product characteristics: [PDF] 07052018ZA (07-May-2018)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/11/0043-01 3,9 g 1 Papīra maisiņš, 1 deva -
Metrovis 100 mg V/DCP/19/0042 Industrial Veterinaria, S.A., Spānija QJ01XD01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0042-01 100 mg 1 Blisteris, 10 tablete -
V/DCP/19/0042-02 100 mg 2 Blisteris, 10 tablete -
V/DCP/19/0042-03 100 mg 5 Blisteris, 10 tablete -
V/DCP/19/0042-04 100 mg 10 Blisteris, 10 tablete -
V/DCP/19/0042-05 100 mg 25 Blisteris, 10 tablete -
V/DCP/19/0042-06 100 mg 50 Blisteris, 10 tablete -
Metrovis 250 mg V/DCP/19/0043 Industrial Veterinaria, S.A., Spānija QJ01XD01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Metronidazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija;aniMedica Herstellungs GmbH, Vācija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0043-01 250 mg 1 Blisteris, 10 tablete -
V/DCP/19/0043-02 250 mg 2 Blisteris, 10 tablete -
V/DCP/19/0043-03 250 mg 5 Blisteris, 10 tablete -
V/DCP/19/0043-04 250 mg 10 Blisteris, 10 tablete -
V/DCP/19/0043-05 250 mg 25 Blisteris, 10 tablete -
V/DCP/19/0043-06 250 mg 50 Blisteris, 10 tablete -
Canidryl 20 mg 20 mg V/MRP/08/1565 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] 230911LI (07-Oct-2011)
Labelling text: [PDF] 230911M (07-Oct-2011)
Summary of product characteristics: [PDF] 230911ZA (07-Oct-2011)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1565-01 20 mg 1 Blisteris, 6 tablete -
V/MRP/08/1565-02 20 mg 10 Blisteris, 10 tablete -
V/MRP/08/1565-03 20 mg 1 Blisteris, 10 tablete -
V/MRP/08/1565-04 20 mg 1 Blisteris, 14 tablete -
V/MRP/08/1565-05 20 mg 2 Blisteris, 10 tablete -
V/MRP/08/1565-06 20 mg 2 Blisteris, 14 tablete -
V/MRP/08/1565-07 20 mg 3 Blisteris, 10 tablete -
V/MRP/08/1565-08 20 mg 3 Blisteris, 14 tablete -
V/MRP/08/1565-09 20 mg 5 Blisteris, 10 tablete -
V/MRP/08/1565-10 20 mg 4 Blisteris, 14 tablete -
V/MRP/08/1565-11 20 mg 6 Blisteris, 10 tablete -
V/MRP/08/1565-12 20 mg 5 Blisteris, 14 tablete -
V/MRP/08/1565-13 20 mg 7 Blisteris, 10 tablete -
V/MRP/08/1565-14 20 mg 6 Blisteris, 14 tablete -
V/MRP/08/1565-15 20 mg 7 Blisteris, 14 tablete -
V/MRP/08/1565-16 20 mg 10 Blisteris, 14 tablete -
V/MRP/08/1565-17 20 mg 14 Blisteris, 10 tablete -
V/MRP/08/1565-18 20 mg 18 Blisteris, 10 tablete -
V/MRP/08/1565-19 20 mg 20 Blisteris, 10 tablete -
V/MRP/08/1565-20 20 mg 25 Blisteris, 10 tablete -
V/MRP/08/1565-21 20 mg 28 Blisteris, 10 tablete -
V/MRP/08/1565-22 20 mg 20 Blisteris, 14 tablete -
V/MRP/08/1565-23 20 mg 30 Blisteris, 10 tablete -
V/MRP/08/1565-24 20 mg 50 Blisteris, 10 tablete -
V/MRP/08/1565-25 20 mg 100 Blisteris, 10 tablete -
V/MRP/08/1565-26 20 mg 1 ABPE konteiners, 6 tablete -
V/MRP/08/1565-27 20 mg 1 ABPE konteiners, 10 tablete -
V/MRP/08/1565-28 20 mg 1 ABPE konteiners, 14 tablete -
V/MRP/08/1565-29 20 mg 1 ABPE konteiners, 20 tablete -
V/MRP/08/1565-30 20 mg 1 ABPE konteiners, 28 tablete -
V/MRP/08/1565-31 20 mg 1 ABPE konteiners, 30 tablete -
V/MRP/08/1565-32 20 mg 1 ABPE konteiners, 42 tablete -
V/MRP/08/1565-33 20 mg 1 ABPE konteiners, 50 tablete -
V/MRP/08/1565-34 20 mg 1 ABPE konteiners, 60 tablete -
V/MRP/08/1565-35 20 mg 1 ABPE konteiners, 70 tablete -
V/MRP/08/1565-36 20 mg 1 ABPE konteiners, 84 tablete -
V/MRP/08/1565-37 20 mg 1 ABPE konteiners, 98 tablete -
V/MRP/08/1565-38 20 mg 1 ABPE konteiners, 100 tablete -
V/MRP/08/1565-39 20 mg 1 ABPE konteiners, 140 tablete -
V/MRP/08/1565-40 20 mg 1 ABPE konteiners, 180 tablete -
V/MRP/08/1565-41 20 mg 1 ABPE konteiners, 200 tablete -
V/MRP/08/1565-42 20 mg 1 ABPE konteiners, 250 tablete -
V/MRP/08/1565-43 20 mg 1 ABPE konteiners, 280 tablete -
V/MRP/08/1565-44 20 mg 1 ABPE konteiners, 300 tablete -
V/MRP/08/1565-45 20 mg 1 ABPE konteiners, 500 tablete -
V/MRP/08/1565-46 20 mg 1 ABPE konteiners, 1000 tablete -
Canidryl 100 mg 100 mg V/MRP/08/1567 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 07-Oct-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOC] 230320LI (23-Mar-2020)
Labelling text: [DOC] 230320M (23-Mar-2020)
Summary of product characteristics: [DOC] 230320ZA (23-Mar-2020)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1567-01 100 mg 1 Blisteris, 6 tablete -
V/MRP/08/1567-02 100 mg 1 Blisteris, 10 tablete -
V/MRP/08/1567-03 100 mg 1 Blisteris, 14 tablete -
V/MRP/08/1567-04 100 mg 2 Blisteris, 10 tablete -
V/MRP/08/1567-05 100 mg 2 Blisteris, 14 tablete -
V/MRP/08/1567-06 100 mg 3 Blisteris, 10 tablete -
V/MRP/08/1567-07 100 mg 3 Blisteris, 14 tablete -
V/MRP/08/1567-08 100 mg 5 Blisteris, 10 tablete -
V/MRP/08/1567-09 100 mg 4 Blisteris, 14 tablete -
V/MRP/08/1567-10 100 mg 6 Blisteris, 10 tablete -
V/MRP/08/1567-11 100 mg 5 Blisteris, 14 tablete -
V/MRP/08/1567-12 100 mg 6 Blisteris, 14 tablete -
V/MRP/08/1567-13 100 mg 7 Blisteris, 14 tablete -
V/MRP/08/1567-14 100 mg 10 Blisteris, 10 tablete -
V/MRP/08/1567-15 100 mg 10 Blisteris, 14 tablete -
V/MRP/08/1567-16 100 mg 18 Blisteris, 10 tablete -
V/MRP/08/1567-17 100 mg 20 Blisteris, 10 tablete -
V/MRP/08/1567-18 100 mg 25 Blisteris, 10 tablete -
V/MRP/08/1567-19 100 mg 20 Blisteris, 14 tablete -
V/MRP/08/1567-20 100 mg 30 Blisteris, 10 tablete -
Prazitel 230/20 mg - V/MRP/14/0021 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 cats Vairāk

Medicinal product information

Pharmaceutical form: flavoured film-coated tablets
International name (active substance): Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 06-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0021-01 2 Blisteris, 1 tablete -
V/MRP/14/0021-02 4 Blisteris, 1 tablete -
V/MRP/14/0021-03 6 Blisteris, 1 tablete -
V/MRP/14/0021-04 8 Blisteris, 1 tablete -
V/MRP/14/0021-05 10 Blisteris, 1 tablete -
V/MRP/14/0021-06 12 Blisteris, 1 tablete -
V/MRP/14/0021-07 14 Blisteris, 1 tablete -
V/MRP/14/0021-08 16 Blisteris, 1 tablete -
V/MRP/14/0021-09 18 Blisteris, 1 tablete -
V/MRP/14/0021-10 20 Blisteris, 1 tablete -
V/MRP/14/0021-11 24 Blisteris, 1 tablete -
V/MRP/14/0021-12 28 Blisteris, 1 tablete -
V/MRP/14/0021-13 30 Blisteris, 1 tablete -
V/MRP/14/0021-14 32 Blisteris, 1 tablete -
V/MRP/14/0021-15 36 Blisteris, 1 tablete -
V/MRP/14/0021-16 40 Blisteris, 1 tablete -
V/MRP/14/0021-17 42 Blisteris, 1 tablete -
V/MRP/14/0021-18 44 Blisteris, 1 tablete -
V/MRP/14/0021-19 48 Blisteris, 1 tablete -
V/MRP/14/0021-20 50 Blisteris, 1 tablete -
Canicaral vet 40 mg V/DCP/15/0021 Le Vet Beheer B.V., Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0021-01 40 mg 1 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-02 40 mg 2 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-03 40 mg 3 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-04 40 mg 4 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-05 40 mg 5 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-06 40 mg 6 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-07 40 mg 7 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-08 40 mg 8 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-09 40 mg 9 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-10 40 mg 10 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-11 40 mg 25 PA/Al/PVH//Al blisteris, 10 tablete -
V/DCP/15/0021-12 40 mg 50 PA/Al/PVH//Al blisteris, 10 tablete -
Canicaral vet 160 mg V/DCP/15/0022 Le Vet Beheer B.V., Nīderlande QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
Date of authorisation/renewal: 21-Sep-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-May-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/15/0022-01 160 mg 1 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-02 160 mg 2 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-03 160 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-04 160 mg 4 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-05 160 mg 5 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-06 160 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-07 160 mg 7 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-08 160 mg 8 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-09 160 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-10 160 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-11 160 mg 25 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/15/0022-12 160 mg 50 Al/OPA/Al/PVH blisteris, 10 tablete -
Cevaxel-RTU 50 mg/ml V/DCP/11/0014 Ceva Sante Animale', Francija QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale., Francija
Date of authorisation/renewal: 29-Dec-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0014-01 50 mg/ml 1 Plastmasas pudele, 100 ml -
V/DCP/11/0014-02 50 mg/ml 1 Plastmasas pudele, 250 ml -
V/DCP/11/0014-03 50 mg/ml 1 Plastmasas pudele, 50 ml -
Ubroseal blue Dry Cow 2.6 g V/DCP/18/0004 Univet Ltd., Īrija QG52X cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Bismuth subnitrate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Univet Ltd., Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (17-Nov-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (17-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0004-01 2,6 g 20 Injektors, 1 deva -
V/DCP/18/0004-02 2,6 g 60 Injektors, 1 deva -
V/DCP/18/0004-03 2,6 g 120 Injektors, 1 deva -
Doxybactin vet 50 mg V/DCP/17/0031 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0031-01 50 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-02 50 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-03 50 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-04 50 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0031-05 50 mg 10 Kastīte ar blisteri, 10 tablete -
Doxybactin vet 200 mg V/DCP/17/0032 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0032-01 200 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-02 200 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-03 200 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-04 200 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0032-05 200 mg 10 Kastīte ar blisteri, 10 tablete -
Doxybactin vet 400 mg V/DCP/17/0033 Dechra Regulatory B.V., Nīderlande QJ01AA02 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Doxycyclin hyclate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 26-Aug-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0033-01 400 mg 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-02 400 mg 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-03 400 mg 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-04 400 mg 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/17/0033-05 400 mg 10 Kastīte ar blisteri, 10 tablete -
Respisure 1 One - V/NRP/03/1567 Elanco GmbH, Vācija QI09AB13 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Mycoplasma hyopneumoniae, strain NL1042, inactivated
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Laboratorios SYVA S.A., Spānija
Date of authorisation/renewal: 15-Jul-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (15-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (15-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/03/1567-02 10 Flakons, 50 deva -
V/NRP/03/1567-03 4 Flakons, 125 deva -
SELIVERM 15 mg V/DCP/24/0045 Bioveta, a.s., Čehija QP54AA05 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 27-Jun-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jun-2024)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (10-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0045-01 3 Tūbiņa(Alu/PE) ar PP elastomēra uzgali, 0,25 ml -
V/DCP/24/0045-02 6 Tūbiņa(Alu/PE) ar PP elastomēra uzgali, 0,25 ml -

3082 records

© Food and veterinary service · 2026 Cookies policy